Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(9 sites)

China

Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu

Huashan Hospital of Fudan University, Shanghai, Shanghai Municipality

Hangzhou First People's Hospital, Hangzhou, Zhejiang

Sir Run Run Shaw Hospital, Zhejiang University School Of Medicine, Hangzhou, Zhejiang

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang

Changxing People's Hospital, Huzhou, Zhejiang

The First Hospital of Jiaxing, Jiaxing, Zhejiang

Ningbo First Hospital, Ningbo, Zhejiang

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang